<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21384" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Ethanol</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mathew</surname>
            <given-names>Fleming</given-names>
          </name>
          <aff>Sharda University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Goyal</surname>
            <given-names>Amandeep</given-names>
          </name>
          <aff>University of Kansas Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Fleming Mathew declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amandeep Goyal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>8</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21384.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p content-type="pubmed-excerpt">Ethanol is an alcohol&#x000a0;that may be administered clinically to&#x000a0;treat methanol and ethylene glycol toxicity and is&#x000a0;applied to surfaces for&#x000a0;disinfection and sterilization. Ethanol has also emerged as a novel cancer therapy, offering an alternative to surgical interventions. The activity&#x000a0;discusses the indications, mechanism of action, administration, adverse effects, and contraindications for ethanol administration. Understanding&#x000a0;ethanol's pharmacology enables healthcare professionals to optimize dosing and minimize adverse reactions. Emphasis is placed on the crucial role of the interprofessional healthcare team in managing ethanol therapy. This discussion equips healthcare professionals with the knowledge&#x000a0;required&#x000a0;to safely and effectively administer ethanol,&#x000a0;improving patient outcomes and care standards.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the therapeutic&#x000a0;indications&#x000a0;for ethanol administration.</p></list-item><list-item><p>Evaluate the mechanisms&#x000a0;contributing to ethanol's clinical efficacy across various clinical&#x000a0;applications.</p></list-item><list-item><p>Determine&#x000a0;the appropriate management of&#x000a0;ethanol toxicity.</p></list-item><list-item><p>Implement effective collaboration and communication among interprofessional team members to ensure appropriate candidate selection for percutaneous ethanol ablation&#x000a0;versus surgery, thereby minimizing surgery-related comorbidities and optimizing patient outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21384&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21384">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21384.s2" sec-type="Indications">
        <title>Indications</title>
        <p>Ethanol is formed during the fermentation of naturally occurring sugars. This chemical's structure consists of&#x000a0;a pair of carbon atoms with an alkyl group coupled with an -OH functional group; this -OH group makes the molecule an alcohol, denoted by the "-ol" suffix.&#x000a0;Unlike other alcohols (eg, methanol, butanol, propanol), humans can consume ethanol in its purest form without&#x000a0;dying.&#x000a0;</p>
        <p>
<bold>Indications</bold>
</p>
        <p>Clinicians may already be aware of the common clinical uses for ethanol, including as a hand sanitizer to prevent healthcare-associated infections (HCAIs) and as part of lock therapy to reduce the incidence of IV catheter-related bloodstream&#x000a0;infections (CRBIs).<xref ref-type="bibr" rid="article-21384.r1">[1]</xref><xref ref-type="bibr" rid="article-21384.r2">[2]</xref>&#x000a0;The&#x000a0;administration of ethanol to prevent&#x000a0;toxic metabolite formation&#x000a0;may also be apparent. However, recent evidence suggests ethanol's potential as a novel therapy for the scenarios below.&#x000a0;&#x000a0;</p>
        <p>
<bold>Fomepizole alternative:</bold>
</p>
        <p>Fomepizole is&#x000a0;FDA-approved&#x000a0;to treat&#x000a0;patients with methanol or ethylene glycol poisoning, and it has a far&#x000a0;greater&#x000a0;affinity for ADH than ethanol. Even though fomepizole is a superior antidote,&#x000a0;its limited&#x000a0;availability and a general lack of knowledge&#x000a0;among clinicians regarding&#x000a0;fomepizole's pharmaceutical features have&#x000a0;led to&#x000a0;the continued use of ethanol infusions as a treatment for these patients.<xref ref-type="bibr" rid="article-21384.r3">[3]</xref><xref ref-type="bibr" rid="article-21384.r4">[4]</xref>&#x000a0;</p>
        <p>Ethanol may be administered as an alternative to&#x000a0;fomepizole for patients with:</p>
        <list list-type="bullet">
          <list-item>
            <p>Methanol poisoning: Patients with &#x02265;20 mg/dL plasma methanol should start therapy immediately&#x000a0;<xref ref-type="bibr" rid="article-21384.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Ethylene glycol poisoning&#x000a0;<xref ref-type="bibr" rid="article-21384.r6">[6]</xref></p>
          </list-item>
        </list>
        <p>Commerical preparation of ethanol is no longer available in the USA; reconstitution is required.</p>
        <p>
<bold>Ablative, embolic, or sclerosing agent:</bold>
</p>
        <p>Recent studies have shown that ethanol may be used in specific scenarios listed below.<xref ref-type="bibr" rid="article-21384.r7">[7]</xref></p>
        <p>As an ablative agent for patients with:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypertrophic obstructive cardiomyopathy&#x000a0;<xref ref-type="bibr" rid="article-21384.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p>Thyroid cystic nodules&#x000a0;<xref ref-type="bibr" rid="article-21384.r9">[9]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Single insulinoma (endoscopic ultrasound-guided)&#x000a0;<xref ref-type="bibr" rid="article-21384.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Hepatocellular carcinomas&#x000a0;<xref ref-type="bibr" rid="article-21384.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>Cancer-associated brachial plexus pain&#x000a0;<xref ref-type="bibr" rid="article-21384.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Cancer-associated upper abdominal/splanchnic nerve pain&#x000a0;<xref ref-type="bibr" rid="article-21384.r13">[13]</xref></p>
          </list-item>
        </list>
        <p>As an embolic agent for patients with: Arteriovenous malformations&#x000a0;<xref ref-type="bibr" rid="article-21384.r14">[14]</xref></p>
        <p>As a sclerosing agent:</p>
        <list list-type="bullet">
          <list-item>
            <p>Surgical alternative&#x000a0;<xref ref-type="bibr" rid="article-21384.r15">[15]</xref></p>
          </list-item>
          <list-item>
            <p>Reduce mortality associated with tumor resections&#x000a0;<xref ref-type="bibr" rid="article-21384.r15">[15]</xref></p>
          </list-item>
          <list-item>
            <p>For patients with:
<list list-type="bullet"><list-item><p>Painful musculoskeletal hemangiomas&#x000a0;<xref ref-type="bibr" rid="article-21384.r10">[10]</xref></p></list-item><list-item><p>Painful trigeminal neuralgia&#x000a0;<xref ref-type="bibr" rid="article-21384.r16">[16]</xref></p></list-item><list-item><p>Lymphatic malformations in the neck and mediastinum (CT-guided)&#x000a0;<xref ref-type="bibr" rid="article-21384.r17">[17]</xref></p></list-item><list-item><p>Symptomatic, simple renal cysts&#x000a0;<xref ref-type="bibr" rid="article-21384.r18">[18]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21384.s3" sec-type="Mechanism of Action">
        <title>Mechanism of Action</title>
        <p>
<bold>Antidote</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Methanol poisoning:</bold> Methanol is less toxic than its metabolized counterpart, formic acid. Alcohol dehydrogenase (ADH) converts methanol into formaldehyde. Aldehyde dehydrogenase (ADLH)&#x000a0;converts formaldehyde into formic acid,&#x000a0;a chemical responsible for the harmful effects associated with methanol poisoning, such as vision loss and Parkinsonian movements. This process is the same for ethanol. However, ethanol has a greater affinity for ADH and ADLH than methanol; ethanol administration competitively inhibits methanol metabolism,&#x000a0;reducing the formation of&#x000a0;formic acid.</p>
          </list-item>
          <list-item>
            <p><bold>Ethylene glycol poisoning:</bold>&#x000a0;Similar to methanol, ethylene glycol&#x000a0;is metabolized by ADH in the liver to form glycolaldehyde, which&#x000a0;ALDH converts to glycolic acid. Glycolic acid may be further metabolized into oxalic acid. Glycolic acid is more toxic than ethylene glycol, and oxalic acid can form calcium oxalate crystals in the kidney. Ethanol also has a greater affinity for ADH and ADLH than ethylene glycol and competitively inhibits ethylene glycol metabolism.</p>
          </list-item>
        </list>
        <p>
<bold>Hand Sanitizer and Sepsis Prevention</bold>
</p>
        <p>Many surveys have reported the global burden of healthcare-associated&#x000a0;infections (HCAIs). Alcohols exhibit antimicrobial activity&#x000a0;by denaturing and coagulating proteins&#x000a0;within&#x000a0;the microbial cell wall. Ethanol is also effective&#x000a0;against viruses and can be combined&#x000a0;with other alcohols to&#x000a0;achieve a powerful synergistic effect against various microorganisms.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Ethanol lock therapy (ELT):</bold>&#x000a0;This therapy primarily benefits&#x000a0;patients receiving total parenteral nutrition. An ethanol lock created in the lumen of the IV catheter kills and&#x000a0;prevents the growth of bacteria, significantly reducing catheter-related bloodstream infections (CRBSIs). No reports of bacteria&#x000a0;exhibiting resistance to ethanol have been documented.</p>
          </list-item>
        </list>
        <p>
<bold>Ablative/Sclerosing/Embolic Agent</bold>
</p>
        <p>Ethanol&#x000a0;may be used to&#x000a0;treat various neoplasms, cysts, and vascular malformations or&#x000a0;induce neurolysis. Ethanol is directly toxic and dehydrating to cells that form the&#x000a0;endothelial lining, causing fibrotic changes. This fibrosis leads to ischemia and size reduction of tumors and other hyperplastic growths.<xref ref-type="bibr" rid="article-21384.r19">[19]</xref></p>
      </sec>
      <sec id="article-21384.s4" sec-type="Administration">
        <title>Administration</title>
        <p>
<bold>Available Dosage Forms and Strengths</bold>
</p>
        <p>Ethanol solution is clinically available as a 95% solution in 1.0 mL and 5.0 mL vials for injection and as a 70% solution for use during ethanol lock therapy. Ethanol is also commercially available as a 10% solution. Intravenous&#x000a0;infusion is the preferred method for patients with methanol&#x000a0;or ethylene glycol poisoning. However, ethanol may also be administered orally or through a nasogastric tube.</p>
        <p>
<bold>Adult Dosing</bold>
</p>
        <p>
<bold>Hand sanitizer:</bold>
</p>
        <p>Alcohol-based hand sanitizer (ABHS)&#x000a0;is known to&#x000a0;prevent nosocomial infections. However, the efficacy of these compounds against neutralizing microorganisms is dependent mainly on the effectiveness of their use.&#x000a0;Several studies&#x000a0;recommend applying&#x000a0;2.4&#x000a0;to 3 mL for a minimum of 30 seconds to&#x000a0;ensure maximum possible disinfection.<xref ref-type="bibr" rid="article-21384.r1">[1]</xref></p>
        <p>
<bold>Methanol toxicity:</bold>
</p>
        <p>The loading and maintenance doses should be carefully monitored in an intensive care setting to prevent any toxic&#x000a0;effect of ethanol itself.</p>
        <p>
<bold>Ethanol solution (95%):</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Loading dose (oral or NG tube): 600-700 mg/kg, diluted to &#x02264;20% with water or juice</p>
          </list-item>
        </list>
        <p><bold>Ethanol solution (10%)</bold>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Loading dose (IV):
<list list-type="bullet"><list-item><p>7.6 mL/kg (600 mg/kg) for a patient with a negative blood ethanol level
<list list-type="bullet"><list-item><p>The dose is reduced&#x000a0;for patients with a positive blood&#x000a0;ethanol level</p></list-item></list>
</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Maintenance:
<list list-type="bullet"><list-item><p>Intravenous:
<list list-type="bullet"><list-item><p>0.83 mL/kg/hr (65-155 mg/kg/hr) for healthy patients.</p></list-item><list-item><p>Patients with chronic alcohol use disorder or who&#x000a0;are on hemodialysis&#x000a0;require higher doses.</p></list-item></list>
</p></list-item><list-item><p>Oral:
<list list-type="bullet"><list-item><p>1.5 mL/kg/hr until a plasma ethanol level of 100 mg/dL is achieved.</p></list-item><list-item><p>Patient ethanol levels are obtained hourly until this threshold. Afterward, ethanol levels may be obtained every 2-4 hours.</p></list-item></list>
</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Ethanol lock therapy:</bold>
</p>
        <p>Ethanol lock therapy (ELT) and regular antibiotic therapy&#x000a0;may be co-administered over 4-6 hours.&#x000a0;This&#x000a0;regimen&#x000a0;significantly reduces the incidence&#x000a0;of catheter-related bloodstream infections (CRBSI).</p>
        <p>
<bold>Ablation or sclerosis:</bold>
</p>
        <p>Ethanol is injected directly into the&#x000a0;lesion or parenchyma of the specific organ or tissue.&#x000a0;Clinicians&#x000a0;may&#x000a0;be guided by endoscopic ultrasound or CT.&#x000a0;</p>
        <p>
<bold>Pediatric Dosing</bold>
</p>
        <p>
<bold>Methanol toxicity:</bold>
</p>
        <p>
<bold>Ethanol solution (95%):</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Loading dose (oral): 0.8-1.0 mL/kg</p>
          </list-item>
          <list-item>
            <p>Maintenance (oral): 0.1 mL/kg/h</p>
          </list-item>
        </list>
        <p>
<bold>Ethanol solution (10% = 7.9 g/dL):</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Loading dose (IV): 8-10 mL/kg, not to exceed 200 mL total</p>
          </list-item>
          <list-item>
            <p>Maintenance (IV): 0.83 mL/kg/h</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21384.s5" sec-type="Adverse Effects">
        <title>Adverse Effects</title>
        <p>During the liver's conversion of&#x000a0;ethanol to acetaldehyde,&#x000a0;the electron carrier&#x000a0;NAD<sup>+</sup>&#x000a0;donates 2 electrons&#x000a0;to this reaction. In the process, NAD<sup>+</sup>&#x000a0;is reduced to NADH, increasing the NADH/NAD<sup>+</sup> ratio in the hepatocytes.</p>
        <p>An&#x000a0;elevated NADH/NAD<sup>+</sup> ratio causes:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Ketoacidosis:</bold>&#x000a0;The citric acid (TCA) cycle inhibition increases acetyl-CoA levels. This&#x000a0;excess acetyl-CoA is shunted into the ketogenesis pathway, resulting in increased production of ketoacids (eg, acetoacetic acid).&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Fasting hypoglycemia:</bold> The increased&#x000a0;NADH/NAD<sup>+</sup> ratio inhibits the conversion of malate to oxaloacetate (OAA). The resulting reaction equilibrium forces&#x000a0;OAA to be converted back into malate. Oxaloacetate&#x000a0;may also be converted into&#x000a0;phosphoenolpyruvate (PEP).&#x000a0;By inhibiting the formation of OAA, an elevated&#x000a0;NADH/NAD<sup>+</sup>&#x000a0;ratio impairs gluconeogenesis.</p>
          </list-item>
          <list-item>
            <p><bold>Hepatic steatosis:</bold>&#x000a0;An increased NADH/NAD<sup>+</sup> ratio&#x000a0;stimulates&#x000a0;fatty acid and glycerol-3-phosphate synthesis. These combine to increase TAG levels, resulting in fatty liver.</p>
          </list-item>
        </list>
        <p>Ingested ethanol&#x000a0;is primarily&#x000a0;metabolized in the liver; hepatic damage often accompanies chronic alcohol consumption. This damage&#x000a0;can lead to steatosis, cirrhosis, and hepatic carcinoma. Other affected organs/organ systems include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Gastrointestinal:</bold>&#x000a0;Gastritis, malabsorption, carcinoma&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Cardiovascular:</bold>&#x000a0;Hypertension, cardiomyopathy, arrhythmia</p>
          </list-item>
          <list-item>
            <p><bold>Renal:</bold>&#x000a0;Glomerulonephritis, AKI</p>
          </list-item>
          <list-item>
            <p><bold>Reproductive</bold>: Infertility, premature birth, low birth weight, fetal alcohol syndrome</p>
          </list-item>
          <list-item>
            <p><bold>Pancreas:</bold>&#x000a0;Pancreatitis</p>
          </list-item>
          <list-item>
            <p><bold>Breast:</bold>&#x000a0;Carcinoma&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Neurological/psychiatric:</bold>&#x000a0;Stroke, depression, meningitis, cerebellar degeneration&#x000a0;<xref ref-type="bibr" rid="article-21384.r20">[20]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21384.s6" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Ethanol must not be administered concurrently with fomepizole,&#x000a0;which inhibits ethanol metabolism and prolongs its half-life. This inhibition can result in significantly elevated ethanol levels and possible manifestations of ethanol intoxication. Contraindications to ethanol administration also include pregnancy and breastfeeding.</p>
        <p>
<bold>Hand Sanitizer</bold>
</p>
        <p>Although there is no&#x000a0;objective contraindication for alcohol-based hand sanitizer (ABHS) in any particular medical setting, it&#x000a0;is common knowledge that ABHS doesn't kill&#x000a0;all harmful microorganisms, including the spores of&#x000a0;<italic toggle="yes">Clostridium difficile</italic>.&#x000a0;ABHS is also ineffective against&#x000a0;some protozoan oocysts&#x000a0;(eg, <italic toggle="yes">Cryptosporidium</italic>)&#x000a0;and&#x000a0;non-enveloped viruses (eg, norovirus). Handwashing&#x000a0;using soap and water is more effective against these organisms than ABHS.<xref ref-type="bibr" rid="article-21384.r1">[1]</xref></p>
        <p>
<bold>Ablation</bold>
</p>
        <p>Percutaneous ethanol injection as part of ablation therapy is contraindicated when:</p>
        <list list-type="bullet">
          <list-item>
            <p>Prothrombin time (PT) is less than 40% of&#x000a0;normal</p>
          </list-item>
          <list-item>
            <p>Platelet count &#x0003c;40,000/mm<sup>3</sup>&#x000a0;<xref ref-type="bibr" rid="article-21384.r21">[21]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21384.s7" sec-type="Monitoring">
        <title>Monitoring</title>
        <p>Ethanol&#x000a0;demonstrates zero-order kinetics. Alcohol is primarily absorbed in the proximal small intestine, but a small fraction is also absorbed by the mucosal layer of the mouth, esophagus, and stomach. Alcohol is primarily metabolized in the liver; the rate of oxidation per unit time yields a linear curve. Insulin release stimulates&#x000a0;ethanol metabolism, while conditions like starvation&#x000a0;impair this process.&#x000a0;Alcohol metabolism occurs via an oxidative and non-oxidative pathway. Various enzymes play a role in the oxidative pathway, including&#x000a0;alcohol dehydrogenase (ADH) in the cytosol, aldehyde dehydrogenase (ALDH) in mitochondria, cytochrome P450 (CYP2E1) in microsomes, and catalase in peroxisomes. The non-oxidative pathway&#x000a0;includes&#x000a0;the enzymes fatty acid ethyl ester synthase (FAEES) and phospholipase D (PLD).&#x000a0;The administration of&#x000a0;medications that inhibit the&#x000a0;oxidative pathway enzymes drive non-oxidative metabolism.<xref ref-type="bibr" rid="article-21384.r22">[22]</xref></p>
        <p>In the oxidative pathway, ethanol is first converted to acetaldehyde by alcohol dehydrogenase (ADH) in the cytosol of hepatocytes. NAD<sup>+</sup> serves as an electron carrier for this reaction and&#x000a0;is reduced to NADH. This process significantly reduces the cytosol,&#x000a0;predisposing to&#x000a0;damage by&#x000a0;reactive oxygen species&#x000a0;(ROS) and other byproducts of alcohol metabolism. The drug fomepizole competitively inhibits ADH, preventing the formation of toxic metabolites.&#x000a0;</p>
        <p>Acetaldehyde is further oxidized in the liver by acetaldehyde dehydrogenase (ALDH) to acetic acid, which is converted to acetyl-CoA by acetyl-CoA synthetase. Acetyl-CoA is eventually transformed into acetone through ketoacid intermediates. Acetone is oxidized to CO<sub>2</sub> in the&#x000a0;cardiac and skeletal muscles and the brain.&#x000a0;Administration of&#x000a0;disulfiram (an&#x000a0;acetaldehyde dehydrogenase inhibitor) delays acetaldehyde clearance, causing symptoms&#x000a0;such as nausea, vomiting, chest and abdominal pain, dizziness, and worsening hangover. This&#x000a0;medication&#x000a0;may be used to help&#x000a0;treat alcohol use disorders. Drugs that exhibit properties&#x000a0;similar to&#x000a0;disulfiram&#x000a0;include metronidazole, sulfamethoxazole and trimethoprim, chloramphenicol, quinacrine, first-generation sulfonylureas, griseofulvin, and some cephalosporins&#x000a0;such as cefotetan and cefoperazone.</p>
        <p>The non-oxidative pathway produces fatty acid ethyl esters (FAEEs), which cause tissue damage and form phosphatidyl ethanol from phospholipase D. Given phospholipase D's role in cell signaling, excessive non-oxidative pathway activation can impair this communication.<xref ref-type="bibr" rid="article-21384.r22">[22]</xref>&#x000a0;Transient heart block can occur after alcohol septal ablation procedures, necessitating the insertion of a temporary pacemaker.<xref ref-type="bibr" rid="article-21384.r23">[23]</xref> About 10% of these heart blocks persist and require a permanent pacemaker.</p>
      </sec>
      <sec id="article-21384.s8" sec-type="Toxicity">
        <title>Toxicity</title>
        <p>Alcohol intoxication&#x000a0;causes CNS depression by enhancing the inhibitory effect of GABA on its receptors.&#x000a0;Alcohol also inhibits the&#x000a0;effects of glutamate on NMDA receptors, resulting in disinhibition and a blunted mental state. Ethanol intoxication&#x000a0;manifests as slurred speech, stupor, and gait abnormalities. Severe intoxication may even result in a coma.&#x000a0;</p>
        <p>Clinicians should first correct thiamine (vitamin B1) deficiency, which&#x000a0;often accompanies chronic alcohol use disorder. Electrolyte derangements&#x000a0;should be corrected through appropriate infusion. Extensive counseling is&#x000a0;frequently required&#x000a0;for patients with alcohol use disorder. Some medications that promote alcohol cessation include naltrexone (&#x003bc;-opioid receptor antagonist), disulfiram (negative conditioning), topiramate, and gabapentin.</p>
        <p>Alcohol withdrawal is another common morbidity that arises as a&#x000a0;complication&#x000a0;of alcohol use disorder (AUD).&#x000a0;Alcohol withdrawal syndrome (AWS)&#x000a0;occurs due to&#x000a0;abrupt cessation of alcohol consumption after binge drinking or long-term dependence. The signs and symptoms&#x000a0;range from mild (eg, anxiety, headache, palpitations) to severe (eg, seizures, delirium tremens). The&#x000a0;features of AWS typically arise within 24 hours of&#x000a0;discontinuing alcohol consumption. Treatment&#x000a0;involves supportive therapy for complaints. Any associated comorbidities should be treated with a 'banana bag' of essential vitamins. Severe AWS is an indication for benzodiazepine administration.<xref ref-type="bibr" rid="article-21384.r24">[24]</xref></p>
      </sec>
      <sec id="article-21384.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Ethanol has existed as a recreational beverage since the beginning of civilization. Over&#x000a0;the past century, extensive research has demonstrated&#x000a0;ethanol's uses for treating disease. Ethanol&#x000a0;has become indispensable in&#x000a0;preventing hospital-acquired infections as a component of hand sanitizer formulas. Healthcare providers (including clinicians, mid-level providers, nurses, and pharmacists) must&#x000a0;sanitize their hands and wear gloves before&#x000a0;touching the patient or handling equipment (eg, catheter tubes, cannulas). This principle is also the basis of&#x000a0;ethanol lock therapy in an ICU setting to prevent sepsis associated with infected catheters.</p>
        <p>Ethanol is currently being studied as an ablative agent for treating different neoplastic conditions&#x000a0;that cannot be treated with&#x000a0;surgery. The surgeon must evaluate appropriate candidates based on age, financial status, and comorbid conditions to&#x000a0;appropriately recommend&#x000a0;ethanol ablation over classic surgery&#x000a0;for the purpose of preventing mortality.</p>
        <p>Ethanol has been used for decades as a&#x000a0;treatment for methanol or ethylene glycol poisoning. Even though fomepizole has emerged&#x000a0;as a&#x000a0;better antidote&#x000a0;due to&#x000a0;its&#x000a0;superior neutralization of the offending agent, more predictable pharmacokinetics, and lower associated&#x000a0;mortality, many still prefer ethanol due to&#x000a0;its low cost and greater physician familiarity.&#x000a0;&#x000a0;</p>
        <p>Alcohol use disorder remains a global challenge, considering the mortality that correlates with misuse.&#x000a0;More than&#x000a0;135 million&#x000a0;Americans aged 12 and older actively use alcohol.<xref ref-type="bibr" rid="article-21384.r25">[25]</xref>&#x000a0;The clinician must identify&#x000a0;and counsel these patients. If necessary, they should be hospitalized and receive appropriate treatment. The&#x000a0;optimal therapeutic use of ethanol&#x000a0;may be achieved through an interprofessional healthcare team, including clinicians (MDs, DOs, NPs, PAs), nursing staff, and pharmacists, who work collaboratively to achieve optimal patient outcomes with minimal adverse events.</p>
      </sec>
      <sec id="article-21384.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21384&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21384">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21384/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21384">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-21384.s11">
        <title>References</title>
        <ref id="article-21384.r1">
          <label>1</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gold</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Mirza</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Avva</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <chapter-title>Alcohol Sanitizer</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>9</day>
            <pub-id pub-id-type="pmid">30020626</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Opilla</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Kirby</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Edmond</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients.</article-title>
            <source>JPEN J Parenter Enteral Nutr</source>
            <year>2007</year>
            <season>Jul-Aug</season>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>302</fpage>
            <page-range>302-5</page-range>
            <pub-id pub-id-type="pmid">17595439</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ekins</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Rollins</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Duffy</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Gregory</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Standardized treatment of severe methanol poisoning with ethanol and hemodialysis.</article-title>
            <source>West J Med</source>
            <year>1985</year>
            <month>Mar</month>
            <volume>142</volume>
            <issue>3</issue>
            <fpage>337</fpage>
            <page-range>337-40</page-range>
            <pub-id pub-id-type="pmid">3993008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hantson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wittebole</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Haufroid</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Ethanol therapy for methanol poisoning: duration and problems.</article-title>
            <source>Eur J Emerg Med</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>278</fpage>
            <page-range>278-9</page-range>
            <pub-id pub-id-type="pmid">12394629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r5">
          <label>5</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ashurst</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Nappe</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <chapter-title>Methanol Toxicity</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">29489213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brent</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Current management of ethylene glycol poisoning.</article-title>
            <source>Drugs</source>
            <year>2001</year>
            <volume>61</volume>
            <issue>7</issue>
            <fpage>979</fpage>
            <page-range>979-88</page-range>
            <pub-id pub-id-type="pmid">11434452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Le Dar&#x000e9;</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gicquel</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic Applications of Ethanol: A Review.</article-title>
            <source>J Pharm Pharm Sci</source>
            <year>2019</year>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>525</fpage>
            <page-range>525-535</page-range>
            <pub-id pub-id-type="pmid">31604058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dokainish</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lakkis</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.</article-title>
            <source>Eur Heart J</source>
            <year>2009</year>
            <month>May</month>
            <volume>30</volume>
            <issue>9</issue>
            <fpage>1080</fpage>
            <page-range>1080-7</page-range>
            <pub-id pub-id-type="pmid">19233857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hahn</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Na</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Ha</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Ahn</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Sung</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Baek</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Sim</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Baek</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>YJ</given-names>
              </name>
              <collab>Korean Society of Thyroid Radiology (KSThR)</collab>
              <collab>Korean Society of Radiology</collab>
            </person-group>
            <article-title>Ethanol Ablation of the Thyroid Nodules: 2018 Consensus Statement by the Korean Society of Thyroid Radiology.</article-title>
            <source>Korean J Radiol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>609</fpage>
            <page-range>609-620</page-range>
            <pub-id pub-id-type="pmid">30887743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qin</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>XP</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>HX</given-names>
              </name>
            </person-group>
            <article-title>EUS-guided ethanol ablation of insulinomas: case series and literature review.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>93</volume>
            <issue>14</issue>
            <fpage>e85</fpage>
            <pub-id pub-id-type="pmid">25255024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Livraghi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Benedini</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lazzaroni</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Meloni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Torzilli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vettori</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma.</article-title>
            <source>Cancer</source>
            <year>1998</year>
            <month>Jul</month>
            <day>01</day>
            <volume>83</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <page-range>48-57</page-range>
            <pub-id pub-id-type="pmid">9655292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loh</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mirchandani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Eckmann</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Brachial Plexus Chemical Neurolysis with Ethanol for Cancer Pain.</article-title>
            <source>Case Rep Med</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>8628645</fpage>
            <pub-id pub-id-type="pmid">30140288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fujita</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>CT-guided neurolytic splanchnic nerve block with alcohol.</article-title>
            <source>Pain</source>
            <year>1993</year>
            <month>Dec</month>
            <volume>55</volume>
            <issue>3</issue>
            <fpage>363</fpage>
            <page-range>363-366</page-range>
            <pub-id pub-id-type="pmid">8121698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yakes</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Luethke</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Stavros</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Rak</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Hopper</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Dreisbach</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Seibert</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>TE</given-names>
              </name>
            </person-group>
            <article-title>Ethanol embolization of vascular malformations.</article-title>
            <source>Radiographics</source>
            <year>1990</year>
            <month>Sep</month>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>787</fpage>
            <page-range>787-96</page-range>
            <pub-id pub-id-type="pmid">2217971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crawford</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Slotcavage</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Lackman</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Ogilvie</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Ethanol sclerotherapy reduces pain in symptomatic musculoskeletal hemangiomas.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>467</volume>
            <issue>11</issue>
            <fpage>2955</fpage>
            <page-range>2955-61</page-range>
            <pub-id pub-id-type="pmid">19536604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McLeod</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Patton</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Peripheral alcohol injections in the management of trigeminal neuralgia.</article-title>
            <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>104</volume>
            <issue>1</issue>
            <fpage>12</fpage>
            <page-range>12-7</page-range>
            <pub-id pub-id-type="pmid">17428701</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Impellizzeri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Romeo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Borruto</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Granata</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Scalfari</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>De Ponte</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Longo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Sclerotherapy for cervical cystic lymphatic malformations in children. Our experience with computed tomography-guided 98% sterile ethanol insertion and a review of the literature.</article-title>
            <source>J Pediatr Surg</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>45</volume>
            <issue>12</issue>
            <fpage>2473</fpage>
            <page-range>2473-8</page-range>
            <pub-id pub-id-type="pmid">21129570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanna</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Dahniya</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Aspiration and sclerotherapy of symptomatic simple renal cysts: value of two injections of a sclerosing agent.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>1996</year>
            <month>Sep</month>
            <volume>167</volume>
            <issue>3</issue>
            <fpage>781</fpage>
            <page-range>781-3</page-range>
            <pub-id pub-id-type="pmid">8751700</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burton</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>O'Dwyer</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Scudamore</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous ethanol ablation of hepatocellular carcinoma: periprocedural onset alcohol toxicity and pancreatitis following conventional percutaneous ethanol ablation treatment.</article-title>
            <source>Can J Gastroenterol</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>23</volume>
            <issue>8</issue>
            <fpage>554</fpage>
            <page-range>554-6</page-range>
            <pub-id pub-id-type="pmid">19668800</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rusyn</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bataller</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Alcohol and toxicity.</article-title>
            <source>J Hepatol</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>387</fpage>
            <page-range>387-8</page-range>
            <pub-id pub-id-type="pmid">23391479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di Stasi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Buscarini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Livraghi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Giorgio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Salmi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De Sio</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Brunello</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Solmi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Caturelli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Magnolfi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Caremani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Filice</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates.</article-title>
            <source>Scand J Gastroenterol</source>
            <year>1997</year>
            <month>Nov</month>
            <volume>32</volume>
            <issue>11</issue>
            <fpage>1168</fpage>
            <page-range>1168-73</page-range>
            <pub-id pub-id-type="pmid">9399400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zakhari</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Overview: how is alcohol metabolized by the body?</article-title>
            <source>Alcohol Res Health</source>
            <year>2006</year>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>245</fpage>
            <page-range>245-54</page-range>
            <pub-id pub-id-type="pmid">17718403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El-Sabawi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Cha</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Bradley</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Klarich</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Rihal</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Eleid</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Transient Complete Heart Block After Alcohol Septal Ablation: Incidence of Recurrence and Need for Permanent Pacemaker.</article-title>
            <source>Circ Cardiovasc Interv</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>13</volume>
            <issue>8</issue>
            <fpage>e009202</fpage>
            <pub-id pub-id-type="pmid">32757660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r24">
          <label>24</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Canver</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Gomez</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <chapter-title>Alcohol Withdrawal Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>2</month>
            <day>14</day>
            <pub-id pub-id-type="pmid">28722912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21384.r25">
          <label>25</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Nehring</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Freeman</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <chapter-title>Alcohol Use Disorder</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>3</month>
            <day>16</day>
            <pub-id pub-id-type="pmid">28613774</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
